Authorised representative (AR)

Celki International Limited (Branch: Celki Medical Co.)

尚健国际有限公司

Hong Kong MDACS·12 represented devices·8 applicants·Jun 05, 2019 – Sep 20, 2024

Total devices

Applicants

2019

First representation

2024

Most recent

AR overview

Bilingual authorised representative information and contact details

Authorised representative (EN): Celki International Limited (Branch: Celki Medical Co.)
Authorised representative (ZH): 尚健国际有限公司
Phone: 23323366

Timeline

First representation: Jun 05, 2019
Most recent: Sep 20, 2024

Risk class distribution

III

Applicant partnerships

Top manufacturers represented by this AR

Shenyang RMS Medical Tech Co., Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Recent registrations

Latest 15 MDACS listings represented by Celki International Limited (Branch: Celki Medical Co.)

Device	Risk class	Applicant	Registered
Ventilators 通风机	III	Shenzhen Mindray Bio-Medical Electronics Co., Ltd. 深圳迈瑞生物医疗电子股份有限公司试剂厂	Sep 20, 2024
Positive Airway Pressure Units, Continuous 气道正压通气单位,连续	II	ResMed Pty Ltd Resmed	Sep 02, 2024
Recorders, Physiologic, Sleep/Awake 录音机, 生理, 睡眠/清醒	II	Nox Medical Nox Medical	Apr 03, 2024
Recorders, Physiologic, Sleep/Awake 录音机, 生理, 睡眠/清醒	II	Nox Medical Nox Medical	Mar 21, 2024
Aspirators, Breast 吸液器,乳房	II	Medela AG Medela Ag	Nov 22, 2023
Monitors, Physiologic, Blood Gas, Bedside, Transcutaneous 监护仪,生理,血气,床旁,经皮	III	SenTec AG SenTec AG	Aug 18, 2022
Aspirators, Breast 吸液器,乳房	II	Medela AG Medela Ag	Jul 15, 2020
Aspirators, Breast 吸液器,乳房	II	Medela AG Medela Ag	Jul 15, 2020
Phototherapy Units, Visible Light, Hyperbilirubinemia 光疗单元、可见光、高胆红素血症	II	Neomedlight Neomedlight	Jun 23, 2020
Positive Airway Pressure Units, Continuous 气道正压通气单位,连续	II	Shenyang RMS Medical Tech Co., Ltd. 沈阳迈思医疗科技有限公司	Jan 24, 2020
Oxygen Concentrators 制氧机	II	Inogen, Inc. Inogen, Inc.	Jun 05, 2019
Oxygen Concentrators 制氧机	II	Inogen, Inc. Inogen, Inc.	Jun 05, 2019

About this profile

Celki International Limited (Branch: Celki Medical Co.) serves as the authorised representative for 12 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.